1.The effect of a new steroid aerosol--beclomethasone dipropionate (Becotide) in chronic asthma.
Singapore medical journal 1974;15(2):106-109
Administration, Topical
;
Adolescent
;
Adult
;
Aerosols
;
Anti-Inflammatory Agents
;
administration & dosage
;
Asthma
;
drug therapy
;
Beclomethasone
;
administration & dosage
;
therapeutic use
;
Female
;
Glucocorticoids
;
Humans
;
Male
;
Middle Aged
;
Prednisolone
;
administration & dosage
;
therapeutic use
;
Time Factors
2.Prediction nomograms for lung function measurements in adult Chinese.
Singapore medical journal 1971;12(4):193-198
Adult
;
Age Factors
;
Aged
;
Asian Continental Ancestry Group
;
Body Height
;
Body Weight
;
China
;
Female
;
Humans
;
Lung Diseases
;
diagnosis
;
Male
;
Middle Aged
;
Probability
;
Respiratory Function Tests
;
standards
;
Singapore
3.Studies on new sympathomimetic beta-receptor stimulating drugs in asthmatic patients. I. The bronchodilator and circulatory effects of subcutaneous terbutaline.
Singapore medical journal 1973;14(2):120-123
Adolescent
;
Adrenergic beta-Agonists
;
therapeutic use
;
Adult
;
Asthma
;
drug therapy
;
Bronchodilator Agents
;
therapeutic use
;
Butylamines
;
therapeutic use
;
Ethanolamines
;
therapeutic use
;
Female
;
Heart Rate
;
drug effects
;
Hemodynamics
;
drug effects
;
Humans
;
Injections, Subcutaneous
;
Male
;
Regional Blood Flow
;
drug effects
;
Resorcinols
;
therapeutic use
4.Peak expiratory flow rate in normal adult Chinese in Singapore.
Singapore medical journal 1973;14(4):511-514
Adolescent
;
Adult
;
Age Factors
;
Aged
;
Body Height
;
Body Weight
;
China
;
Continental Population Groups
;
Female
;
Humans
;
Male
;
Middle Aged
;
Singapore
;
Spirometry
5.Studies of new sympathomimetic beta-receptor stimulating drugs in asthmatic patients. IV Acomparative trial of subcutaneous terbutaline (Bricanyl) and salbutamol (Ventolin).
J L Da COSTA ; B K GOH ; P C TEOH
Singapore medical journal 1976;17(1):7-9
Adolescent
;
Adult
;
Aged
;
Albuterol
;
pharmacology
;
therapeutic use
;
Asthma
;
drug therapy
;
Child
;
Female
;
Heart Rate
;
drug effects
;
Humans
;
Male
;
Middle Aged
;
Terbutaline
;
pharmacology
;
therapeutic use
6.Studies of new sympathomimetic beta-receptor stimulating drugs in asthmatic patients. III. A comparative trial of subcutaneous terbutaline and trimetoquinol.
J L Da COSTA ; B K GOH ; H Y LEE ; P C TEOH
Singapore medical journal 1975;16(2):143-146
Adolescent
;
Adult
;
Asthma
;
drug therapy
;
Czechoslovakia
;
History of Medicine
;
Humans
;
Injections, Subcutaneous
;
Isoquinolines
;
administration & dosage
;
Mental Disorders
;
drug therapy
;
Psychiatry
;
history
;
Terbutaline
;
administration & dosage
;
therapeutic use
;
Tranquilizing Agents
;
history
;
therapeutic use
;
Tretoquinol
;
administration & dosage
;
therapeutic use
7.Antiphospholipid syndrome manifesting as papilledema
Nadir A M ALI ; I TAJUNISAH ; V SUBRAYAN ; S C REDDY ; K J GOH
International Eye Science 2007;7(6):1522-1525
·AIM: To report a rare case of antiphospholipid syndrome presenting as papilledema and sixth nerve palsy in right eye due to superior sagittal sinus thrombosis, and regression of papilledema following anticoagulation and acetazolamide therapy.·METHODS: A 44-year-old Chinese gentleman presented with headache, diplopia and mild blurring of vision. Clinical examination revealed the presence of sixth nerve palsy in right eye and papilledema. There was enlargement of blind spot in the visual fields and red green deficiency in both eyes.Computed tomography and magnetic resonance imaging showed superior sagittal sinus thrombosis. Hematological investigation confirmed the presence of antiphospholipid syndrome as the underlying cause.·RESULTS: The condition was treated successfully in three months with the adjunctive use of anticoagulation and acetazolamide. Reversal of papilledema changes in the optic disc to normal indicates the anatomical recovery, while reduction of enlargement of blind spot to normal size,recovery of red green deficieny to normal colour vision in both eyes and visual improvement after regression of papilledema in right eye indicate functional recovery in this patient.·CONCLUSION: Antiphospholipid syndrome should be considered in the differential diagnosis of papilledema, and oral acetazolamide is an important adjunct therapy to anticoagulation in cases of refractory papilledema to protect the optic nerve from potential damage which results in blindness.
8.The frequency of symptomatic sensory polyneuropathyin the elderly in an urban Malaysian community
T L Lor, K Y Boon ; F F Cheo ; S C Lau ; G W Lee ; B H Ng ; K J Goh
Neurology Asia 2009;14(2):109-113
Background: Neuropathic symptoms and signs are common in the elderly and are often considered
normal fi ndings. However, symptomatic polyneuropathy may contribute to disability and falls in the
elderly. The prevalence of peripheral neuropathy in the elderly in Malaysia has not been previously
reported. The objective of this pilot study is to determine the frequency of symptomatic sensory
polyneuropathy in a group of elderly subjects in the community and their possible associated factors.
Methods: Cross sectional survey of subjects aged 65 years and above, carried out in an urban
neighbourhood in Petaling Jaya. Using a standardised questionnaire, subjects were asked about
sensory neuropathic symptoms, associated medical conditions and social habits. They were examined
for the ankle refl ex, vibration, joint position, and pinprick sensations. Possible symptomatic sensory
polyneuropathy was defi ned as bilateral distal neuropathic symptoms, loss of pinprick sensation and
proprioception sense. Results: Of the 100 subjects, 63% had neuropathic symptoms and signs and
20% had possible symptomatic sensory polyneuropathy. Subjects with polyneuropathy complained
of more postural instability and giddiness and distal weakness. Diabetes mellitus was associated with
the presence of neuropathic symptoms and signs but not with polyneuropathy. Age was signifi cantly
associated with polyneuropathy.
Conclusion: The frequency of symptomatic sensory polyneuropathy in a group of elderly subj
9.The use of midazolam and haloperidol in cancer patients at the end of life.
L K Radha KRISHNA ; V J POULOSE ; C GOH
Singapore medical journal 2012;53(1):62-66
INTRODUCTIONThis study aimed to describe the patterns of sedative use among terminally ill cancer patients who were referred to a hospital-based specialist palliative care service for symptom management. It also aimed to examine whether sedative use among terminally ill cancer patients during the last two days of life had any impact on their survival.
METHODSA retrospective review of case notes was carried out for patients with a diagnosis of terminal cancer, who died in a 95-bedded oncology ward between September 2006 and September 2007. Data was collected on patient characteristics, duration of palliative care, indications and doses of sedatives used at 48 hours and 24 hours before death.
RESULTSA total of 238 patients died while receiving specialist palliative care, 132 of whom (55.5%) were female. At 48 hours and 24 hours before death, 22.6% and 24.8% of patients, respectively, were on sedatives like midazolam, haloperidol or both. The median dose of midazolam was 5 mg/day while the haloperidol dose at 48 hours and 24 hours before death was 3 mg/day and 4 mg/day, respectively. The indications for midazolam were anxiety, breathlessness and stiffness, while those for haloperidol were confusion agitation and nausea. Survival analysis showed no significant difference in survival between patients who were on sedatives and those who were not. The p-value for log-rank test was 0.78.
CONCLUSIONThe results showed that the doses and overall frequency of sedative use in this patient population tended to be low and that usage of sedatives had no deleterious influence on survival.
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Analgesics, Opioid ; therapeutic use ; Female ; Haloperidol ; therapeutic use ; Humans ; Hypnotics and Sedatives ; therapeutic use ; Male ; Midazolam ; therapeutic use ; Middle Aged ; Neoplasms ; drug therapy ; mortality ; Palliative Care ; methods ; Retrospective Studies ; Terminal Care ; methods ; Terminally Ill ; Time Factors ; Treatment Outcome
10.Cystic neoplasms of the pancreas: current diagnostic modalities and management.
Dennis Z W NG ; Brian K P GOH ; Elizabeth H W THAM ; Stephanie M YOUNG ; London Lucien P J OOI
Annals of the Academy of Medicine, Singapore 2009;38(3):251-259
Cystic neoplasm of the pancreas is a relatively uncommon condition covering a wide spectrum of pathology. The increasing incidence as a result of routine imaging tests in asymptomatic patients presents a diagnostic and therapeutic problem to the clinician. This paper discusses the role of the various investigative modalities in the management of cystic neoplasia of the pancreas.
Cystadenoma
;
diagnosis
;
therapy
;
Pancreatic Neoplasms
;
diagnosis
;
therapy